Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid [Forbes]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Forbes
The celebrity doctor's 2022 financial disclosure for his Senate run details holdings in stocks like UnitedHealth, CVS and Johnson & Johnson — potentially creating conflicts in the way he runs Medicare and Medicaid programs. M ehmet Oz, the celebrity doctor that President-Elect Donald Trump has tapped to lead the Centers for Medicare & Medicaid Services, is perhaps best known for his hawking of supplements and weight loss drugs. But he also holds significant investments in traditional healthcare and health insurance stocks that raise questions about potential conflicts of interest, as he is poised to take control of the government agency that oversees healthcare for more than 160 million Americans. According to his 2022 financial disclosure from his Pennsylvania Senate candidacy, Oz holds millions of dollars in stock at healthcare companies, including at least $280,000 in insurer UnitedHealth, $50,000 in pharmacy giant CVS, $50,000 in drug maker AbbVie, $15,000 each in Bristol-M
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]Yahoo! Finance
- Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]Yahoo! Finance
- Ophthalmic Equipment Market Size to Hit USD 105.20 Billion by 2033 | Straits Research [Yahoo! Finance]Yahoo! Finance
- EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision [Yahoo! Finance]Yahoo! Finance
- Which Is A Better Pick: JNJ Stock Or AbbVie? [Forbes]Forbes
JNJ
Earnings
- 10/15/24 - Beat
JNJ
Sec Filings
- 11/13/24 - Form 13F-HR
- 11/6/24 - Form 25-NSE
- 10/31/24 - Form 4/A
- JNJ's page on the SEC website